U.S. Markets open in 7 hrs 25 mins

BridgeBio prices IPO at $17 a share, above its $14 to $16 price range

Ciara Linnane

BridgeBio Pharma Inc. priced its initial public offering late Wednesday at $17 a share, above its price range of $14 to $16. The biotech sold 20.5 million shares to raise $348.5 million. The stock will start trading later Thursday on Nasdaq, under the ticker symbol "BBIO."